Pyle R B, Blomberg D J, Burke M D, Lindsay W G, Nicoloff D M
J Thorac Cardiovasc Surg. 1976 Jun;71(6):884-90.
The diagnosis of acute myocardial infarction (AMI) in the early postoperative period may be quite difficult in certain patients. Electrocardiograms fail to be diagnostic of AMI in as many as one third of patients with myocardial injury found at autopsy. Enzyme patterns commonly used to diagnose AMI in patients admitted to coronary care units are obscured by muscle injury, medications, cardioversion, surgical manipulation, and blood transfusion. The MB isoenzyme of creatinine phosphokinase (CPK) has been described as a specific indicator of myocardial injury. Therefore the CPK-MB isoenzyme level was evaluated as a potential aid in the diagnosis of AMI in the early postoperative period. Thirty patients undergoing cardiac surgery and 7 patients undergoing thoracic surgery not involving the heart were studied. CPK-MB isoenzyme was present in the serum in 10 of 30 patients after cardiac surgery but in none of 7 patients after thoracic surgery. The presence of CPK-MB isoenzyme was found to be a valuable adjunctive indicator in the diagnosis of AMI in the early postoperative period.
对于某些患者而言,术后早期急性心肌梗死(AMI)的诊断可能颇具难度。在尸检发现有心肌损伤的患者中,多达三分之一的患者心电图无法诊断出AMI。用于诊断冠心病监护病房患者AMI的常用酶谱会被肌肉损伤、药物、心脏复律、手术操作及输血所掩盖。肌酸磷酸激酶(CPK)的MB同工酶被认为是心肌损伤的特异性指标。因此,CPK-MB同工酶水平被评估为术后早期诊断AMI的潜在辅助手段。研究了30例接受心脏手术的患者以及7例接受非心脏胸部手术的患者。心脏手术后30例患者中有10例血清中存在CPK-MB同工酶,而胸部手术后7例患者中均未发现。结果发现,CPK-MB同工酶的存在是术后早期诊断AMI的一项有价值的辅助指标。